IARYX
Price
$18.80
Change
-$0.01 (-0.05%)
Updated
Sep 20 closing price
VGSNX
Price
$21.46
Change
-$0.07 (-0.33%)
Updated
Sep 20 closing price
Ad is loading...

IARYX vs VGSNX

Header iconIARYX vs VGSNX Comparison
Open Charts IARYX vs VGSNXBanner chart's image
Invesco Real Estate Y
Price$18.80
Change-$0.01 (-0.05%)
VolumeN/A
CapitalizationN/A
Vanguard Real Estate Index Institutional
Price$21.46
Change-$0.07 (-0.33%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
IARYX vs VGSNX Comparison Chart
Loading...
VS
IARYX vs. VGSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IARYX is a StrongBuy and VGSNX is a Buy.

FUNDAMENTALS
Fundamentals
VGSNX has more cash in the bank: 70.5B vs. IARYX (1.04B). VGSNX pays higher dividends than IARYX: VGSNX (4.01) vs IARYX (2.39). IARYX was incepted earlier than VGSNX: IARYX (16 years) vs VGSNX (21 years). IARYX is a more actively managed with annual turnover of: 42.00 vs. VGSNX (9.00). IARYX has a lower initial minimum investment than VGSNX: IARYX (1000) vs VGSNX (5000000). VGSNX annual gain was more profitable for investors over the last year : 26.90 vs. IARYX (20.91). VGSNX return over 5 years is better than : 26.84 vs. IARYX (-12.99).
IARYXVGSNXIARYX / VGSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence16 years21 years-
Gain YTD10.68413.45279%
Front LoadN/AN/A-
Min. Initial Investment100050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.04B70.5B1%
Annual Yield % from dividends2.394.0160%
Returns for 1 year20.9126.9078%
Returns for 3 years-12.853.64-353%
Returns for 5 years-12.9926.84-48%
Returns for 10 years-10.7487.29-12%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KPRX3.620.16
+4.62%
Kiora Pharmaceuticals Inc.
TRU101.141.17
+1.17%
TransUnion
SVRA4.440.01
+0.23%
Savara
KYMR46.44-0.86
-1.82%
Kymera Therapeutics
GALT2.71-0.06
-2.17%
Galectin Therapeutics